Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Menopause Health Center

Font Size

FDA OK's First Non-Hormonal Hot Flash Treatment

WebMD News from HealthDay

The first non-hormonal treatment for menopause-associated hot flashes has been approved by the U.S. Food and Drug Administration.

The agency approved Brisdelle to treat moderate to severe hot flashes. The new drug contains paroxetine, a selective serotonin reuptake inhibitor (SSRI) antidepressant sold under the brand names Paxil and Pexeva. Brisdelle is taken once daily at bedtime.

There are a number of FDA-approved treatments for hot flashes, but all contain either estrogen alone or estrogen plus a progestin. Approval of Brisdelle was based on two clinical trials that included a total of 1,175 postmenopausal women and found that Brisdelle was more effective than a placebo at reducing hot flashes. Common side effects included headache, fatigue and nausea/vomiting.

Paxil and Pexeva carry a warning about an increased risk of suicide in children and young adults. Because Brisdelle contains the same active ingredient as those drugs, a warning about suicide risk is included on the new drug's label.

Brisdelle's label also warns about a possible reduction in the effectiveness of tamoxifen if both medications are used together, and an increased risk of bleeding.

Menopause-associated hot flashes occur in up to 75 percent of women and can persist for five years or longer. While not life-threatening, hot flashes can cause discomfort, embarrassment and sleep disruption.

"There are a significant number of women who suffer from hot flashes associated with menopause and who cannot or do not want to use hormonal treatments," Dr. Hylton Joffe, director of the Division of Bone, Reproductive and Urologic Products in the FDA's Center for Drug Evaluation and Research, said in an agency news release.

Brisdelle is marketed by Noven Therapeutics, LLC. of Miami, Fla.

Today on WebMD

woman walking outdoors
How to handle headaches, night sweats, and more.
mature woman holding fan in face
Symptoms and treatments.
woman hiding face behind hands
11 ways to keep skin bright and healthy.
Is it menopause or something else?
senior couple
mature woman shopping for produce
Alcohol Disrupting Your Sleep
mature couple on boat
mature woman tugging on her loose skin
senior woman wearing green hat
estrogen gene

WebMD Special Sections